KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amgen (AMGN) Equity Ratio (2016 - 2025)

Historic Equity Ratio for Amgen (AMGN) over the last 17 years, with Q4 2025 value amounting to 0.1.

  • Amgen's Equity Ratio rose 4935.78% to 0.1 in Q4 2025 from the same period last year, while for Dec 2025 it was 0.1, marking a year-over-year increase of 4935.78%. This contributed to the annual value of 0.1 for FY2025, which is 4935.78% up from last year.
  • According to the latest figures from Q4 2025, Amgen's Equity Ratio is 0.1, which was up 4935.78% from 0.11 recorded in Q3 2025.
  • Over the past 5 years, Amgen's Equity Ratio peaked at 0.15 during Q1 2021, and registered a low of 0.02 during Q1 2022.
  • In the last 5 years, Amgen's Equity Ratio had a median value of 0.07 in 2023 and averaged 0.08.
  • In the last 5 years, Amgen's Equity Ratio tumbled by 8963.22% in 2022 and then soared by 28955.32% in 2023.
  • Amgen's Equity Ratio (Quarter) stood at 0.11 in 2021, then plummeted by 48.68% to 0.06 in 2022, then increased by 14.1% to 0.06 in 2023, then decreased by 0.24% to 0.06 in 2024, then surged by 49.36% to 0.1 in 2025.
  • Its last three reported values are 0.1 in Q4 2025, 0.11 for Q3 2025, and 0.08 during Q2 2025.